Because n-3 PUFAs reduced aortic valve obstruction, thickness, and calcification by means of ChemR23 in the context of hypercholesterolemia, we finally evaluated the effect of ChemR23 deletion of aortic valve hemodynamics and morphology in the absence of hypercholesterolemia. The gene discussed is CMKLR1; the disease is Hypercholesterolemia.